"10.1371_journal.pone.0113627","plos one","2014-11-21T00:00:00Z","Hanna Nilsson; Erik Lerkevang Grove; Torben Bjerregaard Larsen; Peter Brønnum Nielsen; Flemming Skjøth; Marianne Maegaard; Thomas Decker Christensen","Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Cardiology, Centre for Cardiovascular Research, Aalborg University Hospital, Aalborg, Denmark; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, The Faculty of Medicine, Aalborg University, Aalborg, Denmark","Conceived and designed the experiments: HN ELG TBL PBN FS TDC. Performed the experiments: HN ELG TBL PBN FS MM TDC. Analyzed the data: HN ELG TBL PBN FS TDC. Contributed reagents/materials/analysis tools: HN ELG TBL PBN FS MM TDC. Wrote the paper: HN ELG TBL PBN FS MM TDC.","Erik Lerkevang Grove has received speaker honoraria from AstraZeneca, Baxter, Bayer, Boehringer Ingelheim, Pfizer and Sysmex and serves on advisory boards for AstraZeneca, Bayer, and Bristol-Myers Squibb. Torben Bjerregaard Larsen has served as an investigator for Janssen Scientific Affairs, LLC and Boehringer Ingelheim and has been on the speaker bureaus for Bayer, BMS/Pfizer, Roche Diagnostics, Takeda and Boehringer Ingelheim. Other authors ? none declared. Thomas Decker Christensen has been on the speaker bureaus for AstraZeneca, Boehringer Ingelheim, Pfizer, Takeda and Bristol-Myers Squibb, and has been a member of an advisory board in Bristol-Myers Squibb. No other relationships are present. The project was funded by a non-restricted grant from Takeda, Denmark, and this does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","11","Hanna Nilsson","HN",7,TRUE,6,7,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
